Bombesin (BBN), a 14-amino-acid neuropeptide, has a very high affinity to gastrin-releasing peptide receptors (GRPrs) which are highly expressed in various cancers including prostate cancer, breast cancer, small cell lung cancer, and oral squamous cancer. This evidence concerns the gene GRP and prostate cancer.